Explore 3 Stock Ideas & Industry Insights Download Free Report

BlossomHill Therapeutics, Inc. Common Stock

Company price
14.24 USD -0.22 ( 1.52%)
Last update at 2026-11-10T21:00:00Z
VOLUME
154535
Market Cap
0.00M

Momentum Score

…

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
12.96
Low
14.55
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on BlossomHill Therapeutics (NASDAQ: BLSM) is limited, with filings providing minimal detail on operations or a product pipeline. Because growth drivers are not disclosed, investors should monitor any clinical progress, regulatory milestones or strategic collaborations if announced. The stock may attract investors only if future filings reveal a credible pipeline, commercialization plans or material partnerships.

The most important risks are opaque disclosures, uncertain financial condition and execution/financing risk that could hinder development and produce significant share-price volatility.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
14.46
Dividend Yield
-
Revenue TTM
-
Revenue Per Share
-
Gross Profit TTM
-
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
-
Diluted EPS TTM
-

Peer Comparison*

Sector: Industry:

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
BLSM
BlossomHill Therapeutics, Inc. Common Stock
-0.22
1.52%
14.24 - - - -

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…